Search Results - "Leiter, Madeline"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist by Leiter, Madeline R, Packard, Kathleen A, Qi, Yongyue, Krueger, Steven K

    Published in Heart international (01-01-2019)
    “…Rivaroxaban is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation…”
    Get full text
    Journal Article
  2. 2

    EVALUATION OF RIVAROXABAN ADMINISTRATION FOR ATRIAL FIBRILLATION IN A CARDIOLOGY PRACTICE by Packard, Kathleen A., Leiter, Madeline, Qi, Yongyue, Krueger, Steven

    “…Background Rivaroxaban (Xarelto) is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular…”
    Get full text
    Journal Article